At Stanford University, the CIMAC utilizes innovative technology to perform comprehensive assays of immune phenotype and function for immunotherapy clinical trials. Capabilities include CyTOF mass cytometry, Multiplexed Ion Beam Imaging (MIBI), ATACseq, Single-cell TCRseq and targeted gene expression, high-dimensional flow cytometry, and highly multiplexed Luminex.

The Stanford CIMAC has extensive sample tracking and pathology support from the Human Immune Monitoring Center as well as the CTRU (Biobank OS online database) and the Stanford Tissue/ Histopathology core, and can develop and apply novel algorithms for analyzing specific clinical questions.

Stanford logo

Principal investigators

Photo of Holden Maecker, PhD

Holden Maecker, PhD

Professor, Microbiology and Immunology, Stanford University

Director, Human Immune Monitoring Center

Director, Service Centers and Enabling Technologies

Dr. Maecker’s research uses systems-level immune monitoring assays to understand the correlation between cellular response to pathogens and cancer and protection from clinical disease.

Photo of Sean Bendall, PhD

Sean Bendall, PhD

Assistant Professor, Pathology, Stanford University

Dr. Bendall’s research focuses on using high-content single-cell analysis (CyTOF–Mass Cytometry) and imaging (MIBI–Multiplexed Ion Beam Imaging) to investigate how novel regulators enable the mechanistic characterization of human pathophysiology in primary tissues.